Natalie Aronson Christian

Natalie Aronson Christian is an accomplished professional in the biotechnology and pharmaceutical fields, holding the position of Executive Director at Merck since July 2014, where responsibilities include leading the Manufacturing Strategy Realization & Portfolio Management Office and overseeing the Global Vaccines and Biologics Commercialization Project Leadership Group. Previous roles at Merck encompass Director of Product Leadership and Associate Director of Engineering, focusing on live virus vaccine commercialization and leading project engineers in vaccine manufacturing. Natalie’s earlier experiences include serving as a Senior Specialist in Engineering at Merck and conducting postdoctoral research at the University of Pennsylvania School of Medicine. Academic credentials include a PhD in Bioengineering from the University of Pennsylvania and a BS in Chemical Engineering from the University of Kentucky, with expertise in various areas such as dendritic cell biology and in vivo imaging methodologies.